All Stories

  1. State-of-the-Art Machine Learning Models for Detecting and Mitigating Disparities in Healthcare

    Article • January 2026, Springer Science + Business Media

    David Baldwin

  2. Towards Inclusive AI System Development for Disease Risk Prediction: Collecting, Prioritising and Incorporating User Stories from Heterogeneous Stakeholders

    Article • January 2026, Springer Science + Business Media

    David Baldwin

  3. Utilization of Lung Cancer Registries in Learning Health Systems for Health Care Improvement

    Article • JCO Clinical Cancer Informatics, November 2025, American Society of Clinical Oncology (ASCO)

    David Baldwin

  4. Effective management of incidental findings in lung cancer screening: the role of the screening review meeting

    Article • Clinical Radiology, August 2025, Elsevier

    David Baldwin

  5. Increasing Lung Screening uptake: Exploring people who smoke and their family members concerns and recommendations regarding screening invitations

    Article • Tobacco Prevention & Cessation, January 2025, E.U. European Publishing

    David Baldwin

  6. Explainable Boosting Machines for Lung Cancer Prediction and Explanation

    Article • January 2025, Springer Science + Business Media

    David Baldwin

  7. Decision Tree Models to Select High-Risk Patients for Lung Cancer Screening and Model Interpretability

    Article • January 2025, Springer Science + Business Media

    David Baldwin

  8. Achieving earlier diagnosis of symptomatic lung cancer

    Article • British Journal of General Practice, December 2024, Royal College of General Practitioners

    David Baldwin

  9. Quality assurance in lung cancer screening

    Article • British Journal of Radiology, November 2024, Oxford University Press (OUP)

    David Baldwin

  10. Pulmonary fibrosis and lung cancer: an analysis of the Clinical Practice Research Datalink linked to the National Cancer Registration Dataset

    Article • Thorax, September 2024, BMJ

    David Baldwin

  11. The importance of co-located, high intensity smoking cessation support within lung cancer screening: Findings from the Process Evaluation of the Yorkshire Enhanced Stop Smoking study

    Article • July 2024, Cold Spring Harbor Laboratory Press

    David Baldwin

  12. Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial

    Article • European Respiratory Journal, April 2024, European Respiratory Society (ERS)

    David Baldwin

  13. Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset

    Article • Thorax, November 2023, BMJ

    David Baldwin

  14. Measuring Harms of Lung Cancer Screening

    Article • CHEST Journal, August 2023, Elsevier

    David Baldwin

  15. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models

    Article • The Lancet Respiratory Medicine, August 2023, Elsevier

    David Baldwin

  16. Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD

    Article • ERJ Open Research, July 2023, European Respiratory Society (ERS)

    David Baldwin

  17. The Impact of COVID-19 on Lung Cancer Incidence in England

    Article • CHEST Journal, June 2023, Elsevier

    David Baldwin

  18. Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

    Article • European Respiratory Journal, May 2023, European Respiratory Society (ERS)

    David Baldwin

  19. Defining the road map to a UK national lung cancer screening programme

    Article • The Lancet Oncology, May 2023, Elsevier

    David Baldwin

  20. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals

    Article • JAMA Network Open, March 2023, American Medical Association (AMA)

    David Baldwin

  21. Lung cancer screening

    Article • The Lancet, February 2023, Elsevier

    David Baldwin

  22. Lung nodules: sorting the wheat from the chaff

    Article • British Journal of Radiology, February 2023, Oxford University Press (OUP)

    David Baldwin

  23. Clinical trials in cancer screening, prevention and early diagnosis (SPED): A systematic mapping review

    Article • January 2023, Research Square

    David Baldwin, Dr Dipesh P Gopal

  24. Important parameters for cost-effective implementation of lung cancer screening

    Article • British Journal of Radiology, January 2023, Oxford University Press (OUP)

    David Baldwin

  25. Decision Tree Approaches to Select High Risk Patients for Lung Cancer Screening Based on the UK Primary Care Data

    Article • January 2023, Springer Science + Business Media

    David Baldwin

  26. Logistic Regression Approach to a Joint Classification and Feature Selection in Lung Cancer Screening Using CPRD Data

    Article • January 2023, Springer Science + Business Media

    David Baldwin

  27. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

    Article • BMC Pulmonary Medicine, December 2022, Springer Science + Business Media

    David Baldwin

  28. European Respiratory Society guideline on various aspects of quality in lung cancer care

    Article • European Respiratory Journal, November 2022, European Respiratory Society (ERS)

    David Baldwin, Prof Luciano Mutti

  29. Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial

    Article • Thorax, November 2022, BMJ

    David Baldwin

  30. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership

    Article • Cancer Control, October 2022, SAGE Publications

    David Baldwin

  31. Decision Support Tools for Low-Dose CT Lung Cancer Screening

    Article • CHEST Journal, October 2022, Elsevier

    David Baldwin

  32. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

    Article • July 2022, Cold Spring Harbor Laboratory Press

    David Baldwin

  33. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial

    Article • European Respiratory Journal, July 2022, European Respiratory Society (ERS)

    David Baldwin

  34. Predicting the future risk of lung cancer: development and validation of QCancer2 (10-year risk) lung model and evaluating the model performance of nine prediction models

    Article • June 2022, Cold Spring Harbor Laboratory Press

    David Baldwin

  35. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think‐aloud study

    Article • Health Expectations, June 2022, Wiley

    David Baldwin

  36. The role of computer-assisted radiographer reporting in lung cancer screening programmes

    Article • European Radiology, May 2022, Springer Science + Business Media

    David Baldwin

  37. Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend

    Article • Health Expectations, May 2022, Wiley

    David Baldwin

  38. Implementing Lung Cancer Screening in Europe: Taking a Systems Approach

    Article • JTO Clinical and Research Reports, May 2022, Elsevier

    David Baldwin

  39. Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit

    Article • Thorax, April 2022, BMJ

    David Baldwin

  40. Lung Cancer in the United Kingdom

    Article • Journal of Thoracic Oncology, February 2022, Elsevier

    David Baldwin

  41. Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks

    Article • Journal of Thoracic Oncology, February 2022, Elsevier

    David Baldwin

  42. The Future of Lung Cancer Screening: Current Challenges and Research Priorities

    Article • Cancer Management and Research, February 2022, Taylor & Francis

    David Baldwin

  43. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Article • The Lancet Respiratory Medicine, November 2021, Elsevier

    MD Pilar Rivera Ortega, Dr Omer Elneima, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder, Dr Stephen P McAdoo, David Baldwin, Dr dan Wootton

  44. Analysis of the baseline performance of five UK lung cancer screening programmes

    Article • Lung Cancer, November 2021, Elsevier

    David Baldwin

  45. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

    Article • The Lancet Regional Health - Europe, November 2021, Elsevier

    David Baldwin

  46. Selection of eligible participants for screening for lung cancer using primary care data

    Article • Thorax, October 2021, BMJ

    David Baldwin

  47. What is the Definition of Cure in Non-small Cell Lung Cancer?

    Article • Oncology and Therapy, August 2021, Springer Science + Business Media

    David Baldwin

  48. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study

    Article • Thorax, July 2021, BMJ

    David Baldwin

  49. Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

    Article • BMJ Open Respiratory Research, July 2021, BMJ

    David Baldwin

  50. Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

    Article • British Journal of Cancer, May 2021, Springer Science + Business Media

    David Baldwin

  51. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

    Article • British Journal of Cancer, April 2021, Springer Science + Business Media

    David Baldwin

  52. Factors associated with survival in small cell lung cancer: an analysis of real-world national audit, chemotherapy and radiotherapy data

    Article • Annals of Palliative Medicine, April 2021, AME Publishing Company

    David Baldwin

  53. Participation in lung cancer screening

    Article • Translational Lung Cancer Research, February 2021, AME Publishing Company

    David Baldwin

  54. Importance of research design in biomarkers for lung cancer

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    David Baldwin, David Baldwin

  55. Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation

    Article • Journal of Thoracic Oncology, January 2021, Elsevier

    David Baldwin

  56. Selecting Lung Cancer Patients from UK Primary Care Data: A Longitudinal Study of Feature Trends

    Article • January 2021, Springer Science + Business Media

    David Baldwin

  57. Reply to Wilson: Improving Lung Cancer Screening Uptake

    Article • American Review of Respiratory Disease, October 2020, American Thoracic Society

    Angshu Bhowmik, David Baldwin

  58. Pulmonary nodules

    Article • BMJ, October 2020, BMJ

    David Baldwin

  59. New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study?

    Article • Translational Lung Cancer Research, October 2020, AME Publishing Company

    David Baldwin

  60. An update on CT screening for lung cancer: the first major targeted cancer screening programme

    Article • British Journal of Radiology, September 2020, British Institute of Radiology

    David Baldwin

  61. Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme

    Article • BMJ Open, September 2020, BMJ

    David Baldwin

  62. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk

    Article • BMJ Open, September 2020, BMJ

    David Baldwin

  63. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer

    Article • CHEST Journal, September 2020, Elsevier

    David Baldwin

  64. Lung Screen Uptake Trial: results from a single lung cancer screening round

    Article • Thorax, August 2020, BMJ

    Angshu Bhowmik, David Baldwin

  65. Targeted screening for lung cancer is here but who do we target and how?

    Article • Thorax, July 2020, BMJ

    David Baldwin

  66. SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    David Baldwin

  67. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort

    Article • Annals of the American Thoracic Society, July 2020, American Thoracic Society

    Angshu Bhowmik, David Baldwin

  68. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

    Article • Cancers, June 2020, MDPI AG

    David Baldwin, Dr. Luca Bertolaccini

  69. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials

    Article • American Review of Respiratory Disease, April 2020, American Thoracic Society

    Angshu Bhowmik, David Baldwin

  70. Lung cancer: investigation and staging

    Article • Medicine, April 2020, Elsevier

    David Baldwin

  71. External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules

    Article • Thorax, March 2020, BMJ

    David Baldwin

  72. A systematic review of survival following anti-cancer treatment for small cell lung cancer

    Article • Lung Cancer, March 2020, Elsevier

    David Baldwin

  73. Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

    Article • Thorax, December 2019, BMJ

    David Baldwin

  74. Correction:Defining the information needs of lung cancer screening participants: a qualitative study

    Article • BMJ Open Respiratory Research, December 2019, BMJ

    David Baldwin

  75. Defining the information needs of lung cancer screening participants: a qualitative study

    Article • BMJ Open Respiratory Research, November 2019, BMJ

    David Baldwin

  76. Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening

    Article • European Journal of Radiology, November 2019, Elsevier

    David Baldwin

  77. Evaluation of cardiovascular risk in a lung cancer screening cohort

    Article • Thorax, September 2019, BMJ

    Angshu Bhowmik, David Baldwin

  78. Ex vivo Raman spectroscopy mapping of lung tissue: label-free molecular characterization of nontumorous and cancerous tissues

    Article • Journal of Medical Imaging, August 2019, SPIE

    David Baldwin

  79. Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

    Article • The Lancet Respiratory Medicine, August 2019, Elsevier

    Professor Peter Sasieni, David Baldwin

  80. Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial

    Article • Annals of the American Thoracic Society, June 2019, American Thoracic Society

    Angshu Bhowmik, David Baldwin

  81. Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    David Baldwin

  82. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial

    Article • Thorax, April 2019, BMJ

    David Baldwin

  83. The potential of breath analysis to improve outcome for patients with lung cancer

    Article • Journal of Breath Research, April 2019, Institute of Physics Publishing

    David Baldwin

  84. Status of Lung Cancer Data Collection in Europe

    Article • JCO Clinical Cancer Informatics, December 2018, American Society of Clinical Oncology (ASCO)

    David Baldwin

  85. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

    Article • BMC Cancer, November 2018, Springer Science + Business Media

    Professor Alexandru Corlateanu, David Baldwin

  86. Lung cancer screening – gaining consensus on next steps – proceedings of a closed workshop in the UK

    Article • Lung Cancer, November 2018, Elsevier

    David Baldwin

  87. Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: An analysis of national audit data

    Article • European Journal of Cancer, November 2018, Elsevier

    David Baldwin

  88. ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe

    Article • European Respiratory Journal, October 2018, European Respiratory Society (ERS)

    Prof Luciano Mutti, David Baldwin

  89. EUPS—argues that lung cancer screening should be implemented in 18 months

    Article • British Journal of Radiology, October 2018, Oxford University Press (OUP)

    David Baldwin

  90. Lung cancer screening—low dose CT for lung cancer screening: recent trial results and next steps

    Article • British Journal of Radiology, October 2018, Oxford University Press (OUP)

    David Baldwin

  91. The continuum of screening and early detection, awareness and faster diagnosis of lung cancer

    Article • Thorax, August 2018, BMJ

    David Baldwin

  92. Lung cancer in the UK: addressing geographical inequality and late diagnosis

    Article • The Lancet Oncology, August 2018, Elsevier

    David Baldwin

  93. The Fleischner Society 2017 and British Thoracic Society 2015 guidelines for managing pulmonary nodules: keep calm and carry on

    Article • Thorax, June 2018, BMJ

    David Baldwin

  94. British Thoracic Society quality standards for the investigation and management of pulmonary nodules

    Article • BMJ Open Respiratory Research, April 2018, BMJ

    David Baldwin

  95. Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial

    Article • Translational Lung Cancer Research, April 2018, AME Publishing Company

    David Baldwin

  96. Recent advances in the management of lung cancer

    Article • Clinical Medicine, April 2018, Elsevier

    David Baldwin

  97. Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients

    Article • Thorax, March 2018, BMJ

    David Baldwin

  98. Low-dose CT for lung cancer screening – Authors' reply

    Article • The Lancet Oncology, March 2018, Elsevier

    David Baldwin

  99. Low dose CT screening for lung cancer

    Article • BMJ, December 2017, BMJ

    David Baldwin

  100. European position statement on lung cancer screening

    Article • The Lancet Oncology, December 2017, Elsevier

    David Baldwin

  101. Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial

    Article • Trials, November 2017, Springer Science + Business Media

    Angshu Bhowmik, David Baldwin

  102. Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

    Article • Annals of Translational Medicine, October 2017, AME Publishing Company

    David Baldwin

  103. Use of Volumetry for Lung Nodule Management: Theory and Practice

    Article • Radiology, September 2017, Radiological Society of North America (RSNA)

    David Baldwin

  104. Physician Assessment of Pretest Probability of Malignancy and Adherence to Guidelines for Pulmonary Nodule Evaluation

    Article • CHEST Journal, August 2017, Elsevier

    David Baldwin

  105. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

    Article • Thorax, July 2017, BMJ

    David Baldwin

  106. The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial

    Article • European Radiology, June 2017, Springer Science + Business Media

    David Baldwin

  107. Lung cancer in symptomatic patients presenting in primary care: a systematic review of risk prediction tools

    Article • British Journal of General Practice, May 2017, Royal College of General Practitioners

    David Baldwin

  108. Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study

    Article • Lung Cancer, February 2017, Elsevier

    David Baldwin

  109. Socioeconomic position and delays in lung cancer diagnosis: should we target the more deprived?

    Article • Thorax, December 2016, BMJ

    David Baldwin

  110. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer

    Article • Clinical Oncology, November 2016, Elsevier

    David Baldwin

  111. Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

    Article • Thorax, October 2016, BMJ

    David Baldwin

  112. Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial

    Article • British Journal of Radiology, October 2016, Oxford University Press (OUP)

    David Baldwin

  113. Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with periphe...

    Article • Pilot and Feasibility Studies, September 2016, Springer Science + Business Media

    David Baldwin

  114. Implementation planning for lung cancer screening: five major challenges

    Article • The Lancet Respiratory Medicine, September 2016, Elsevier

    David Baldwin

  115. How should performance in EBUS mediastinal staging in lung cancer be measured?

    Article • British Journal of Cancer, August 2016, Springer Science + Business Media

    David Baldwin

  116. Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013

    Article • PLOS One, August 2016, PLOS

    David Baldwin

  117. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial

    Article • Thorax, July 2016, BMJ

    David Baldwin

  118. Defining a standard set of patient-centred outcomes for lung cancer

    Article • European Respiratory Journal, July 2016, European Respiratory Society (ERS)

    David Baldwin

  119. Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management

    Article • The Lancet Oncology, July 2016, Elsevier

    David Baldwin

  120. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

    Article • British Journal of Cancer, June 2016, Springer Science + Business Media

    David Baldwin

  121. Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries

    Article • Lung Cancer, May 2016, Elsevier

    David Baldwin

  122. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

    Article • Health Technology Assessment, May 2016, National Institute for Health Research

    David Baldwin

  123. Management of pulmonary nodules according to the 2015 British Thoracic Society guidelines. Key messages for clinical practice

    Article • Polish Archives of Internal Medicine, April 2016, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    David Baldwin

  124. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients

    Article • BMC Cancer, April 2016, Springer Science + Business Media

    David Baldwin

  125. Lung cancer: investigation and staging

    Article • Medicine, April 2016, Elsevier

    David Baldwin

  126. Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules

    Article • British Journal of Radiology, March 2016, Oxford University Press (OUP)

    David Baldwin

  127. Pulmonary nodules and CT screening: the past, present and future

    Article • Thorax, February 2016, BMJ

    David Baldwin

  128. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I ...

    Article • Pilot and Feasibility Studies, February 2016, Springer Science + Business Media

    David Baldwin

  129. How should pulmonary nodules be optimally investigated and managed?

    Article • Lung Cancer, January 2016, Elsevier

    David Baldwin

  130. CT screening for lung cancer: Is the evidence strong enough?

    Article • Lung Cancer, January 2016, Elsevier

    David Baldwin

  131. Integrated Raman microscopy and auto-fluorescence imaging for fast tumour diagnosis during cancer surgery

    Article • January 2016, Optical Society of America (OSA)

    David Baldwin

  132. Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

    Article • BMJ Open, January 2016, BMJ

    David Baldwin

  133. Pulmonary nodules again? The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules

    Article • Clinical Radiology, January 2016, Elsevier

    David Baldwin

  134. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

    Article • Thorax, December 2015, BMJ

    David Baldwin

  135. Development of Guidelines for the Management of Pulmonary Nodules Toward Better Implementation

    Article • CHEST Journal, December 2015, Elsevier

    David Baldwin

  136. Correction

    Article • Thorax, November 2015, BMJ

    David Baldwin

  137. Patients’ attitudes to risk in lung cancer surgery: A qualitative study

    Article • Lung Cancer, November 2015, Elsevier

    Dr Laura Jones, David Baldwin

  138. Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators

    Article • European Journal of Cancer, September 2015, Elsevier

    David Baldwin

  139. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial

    Article • BMJ Open, July 2015, BMJ

    David Baldwin

  140. Prediction of risk of lung cancer in populations and in pulmonary nodules: Significant progress to drive changes in paradigms

    Article • Lung Cancer, July 2015, Elsevier

    David Baldwin

  141. Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis

    Article • BMJ Open Respiratory Research, July 2015, BMJ

    David Baldwin

  142. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules

    Article • Thorax, July 2015, BMJ

    David Baldwin

  143. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE

    Article • Thorax, June 2015, BMJ

    David Baldwin

  144. Screening for lung cancer

    Article • British Journal of Hospital Medicine, June 2015, Mark Allen Group

    David Baldwin

  145. Screening

    Article • June 2015, European Respiratory Society (ERS)

    David Baldwin

  146. Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients

    Article • Metabolomics, May 2015, Springer Science + Business Media

    David Baldwin

  147. FDG-PET/CT Imaging for Mediastinal Staging in Patients With Potentially Resectable Non–Small Cell Lung Cancer

    Article • JAMA, April 2015, American Medical Association (AMA)

    David Baldwin

  148. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial

    Article • The Lancet Respiratory Medicine, April 2015, Elsevier

    David Baldwin

  149. Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit

    Article • QJM, February 2015, Oxford University Press (OUP)

    David Baldwin

  150. Author's response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

    Article • Thorax, January 2015, BMJ

    David Baldwin

  151. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer

    Article • Cochrane Database of Systematic Reviews, November 2014, Wiley

    David Baldwin

  152. Next steps and barriers to implementing lung cancer screening with low-dose CT

    Article • British Journal of Radiology, November 2014, Oxford University Press (OUP)

    David Baldwin

  153. Brain metastases following radical surgical treatment of non-small cell lung cancer: Is preoperative brain imaging important?

    Article • Lung Cancer, November 2014, Elsevier

    David Baldwin

  154. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

    Article • Thorax, October 2014, BMJ

    David Baldwin

  155. The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery

    Article • Thorax, September 2014, BMJ

    David Baldwin

  156. Appetite stimulants for people with cystic fibrosis

    Article • Cochrane Database of Systematic Reviews, July 2014, Wiley

    David Baldwin

  157. The European initiative for quality management in lung cancer care

    Article • European Respiratory Journal, March 2014, European Respiratory Society (ERS)

    David Baldwin

  158. Lung cancer screening with low dose computed tomography

    Article • BMJ, March 2014, BMJ

    David Baldwin

  159. The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening

    Article • Cancer Prevention Research, March 2014, American Association for Cancer Research (AACR)

    David Baldwin

  160. Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit

    Article • PLOS One, February 2014, PLOS

    David Baldwin

  161. Multidisciplinary team management in thoracic oncology: more than just a concept?

    Article • European Respiratory Journal, February 2014, European Respiratory Society (ERS)

    David Baldwin

  162. The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) Response to the USPSTF Recommendations

    Article • Journal of Thoracic Oncology, February 2014, Elsevier

    David Baldwin

  163. Effective lung cancer screening is possible

    Article • BMJ, January 2014, BMJ

    David Baldwin

  164. Treatment decisions and survival for people with small-cell lung cancer

    Article • British Journal of Cancer, January 2014, Springer Science + Business Media

    David Baldwin

  165. CT screening for lung cancer: countdown to implementation

    Article • The Lancet Oncology, December 2013, Elsevier

    David Baldwin

  166. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009

    Article • Thorax, October 2013, BMJ

    David Baldwin

  167. Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit

    Article • British Journal of Cancer, September 2013, Springer Science + Business Media

    David Baldwin

  168. European randomized lung cancer screening trials: Post NLST

    Article • Journal of Surgical Oncology, July 2013, Wiley

    PhD Silvio Cavuto, David Baldwin

  169. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit

    Article • Thorax, May 2013, BMJ

    David Baldwin

  170. Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis

    Article • Journal of Thoracic Oncology, April 2013, Elsevier

    David Baldwin

  171. The pathological confirmation rate of lung cancer in England using the NLCA database

    Article • Lung Cancer, February 2013, Elsevier

    David Baldwin

  172. Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier

    Article • Thorax, January 2013, BMJ

    David Baldwin

  173. Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis

    Article • Journal of Thoracic Oncology, January 2013, Elsevier

    David Baldwin

  174. The Association Between Smoking Quantity and Lung Cancer in Men and Women

    Article • CHEST Journal, January 2013, Elsevier

    David Baldwin

  175. Authors' response

    Article • Thorax, August 2012, BMJ

    David Baldwin

  176. Measurement Methods and Algorithms for the Management of Solid Nodules

    Article • Journal of Thoracic Imaging, July 2012, Wolters Kluwer Health

    David Baldwin

  177. A proposed new imaging pathway for patients with suspected lung cancer

    Article • Clinical Radiology, June 2012, Elsevier

    David Baldwin

  178. The (US) National Lung Cancer Screening Trial: intensifying the debate about the introduction of screening for lung cancer

    Article • The Journal of the Royal College of Physicians of Edinburgh, June 2012, SAGE Publications

    David Baldwin

  179. What is the Most Effective Follow-up Model for Lung Cancer Patients? A Systematic Review

    Article • Journal of Thoracic Oncology, May 2012, Elsevier

    David Baldwin

  180. Lung cancer: investigation and staging

    Article • Medicine, April 2012, Elsevier

    David Baldwin

  181. Authors' response

    Article • Thorax, February 2012, BMJ

    David Baldwin

  182. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report

    Article • Journal of Thoracic Oncology, January 2012, Elsevier

    David Baldwin

  183. Supportive Care in Respiratory Disease

    Article • January 2012, Oxford University Press (OUP)

    David Baldwin

  184. Authors' response

    Article • Thorax, September 2011, BMJ

    David Baldwin

  185. How do patient and hospital features influence outcomes in small-cell lung cancer in England?

    Article • British Journal of Cancer, August 2011, Springer Science + Business Media

    David Baldwin

  186. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service

    Article • Thorax, July 2011, BMJ

    David Baldwin

  187. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report

    Article • Thorax, July 2011, BMJ

    David Baldwin

  188. Diagnosis and treatment of lung cancer: summary of updated NICE guidance

    Article • BMJ, April 2011, BMJ

    David Baldwin

  189. Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA)

    Article • Lung Cancer, April 2011, Elsevier

    David Baldwin

  190. Imaging in lung cancer: recent advances in PET-CT and screening

    Article • Thorax, March 2011, BMJ

    David Baldwin

  191. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

    Article • Thorax, February 2011, BMJ

    David Baldwin

  192. Authors' response

    Article • Thorax, November 2010, BMJ

    David Baldwin

  193. Guidelines on the radical management of patients with lung cancer

    Article • Thorax, October 2010, BMJ

    David Baldwin

  194. Diagnosing lung cancer earlier in the UK

    Article • Thorax, August 2010, BMJ

    David Baldwin

  195. Technical validation of an autoantibody test for lung cancer

    Article • Annals of Oncology, August 2010, Elsevier

    David Baldwin

  196. Cardiopulmonary exercise testing for the selection of patients undergoing surgery for lung cancer: friend or foe?

    Article • Thorax, July 2010, BMJ

    David Baldwin

  197. Cytological assessment of conventional transbronchial fine needle aspiration of lymph nodes

    Article • Cytopathology, January 2010, Wiley

    David Baldwin

  198. Lung cancer: investigation and staging

    Article • Medicine, March 2008, Elsevier

    David Baldwin

  199. Appetite stimulants in cystic fibrosis: a systematic review

    Article • Journal of Human Nutrition and Dietetics, November 2007, Wiley

    David Baldwin

  200. BTS statement on malignant mesothelioma in the UK, 2007

    Article • Thorax, November 2007, BMJ

    David Baldwin

  201. NICE guidance for screening for malnutrition: implications for lung cancer services

    Article • Thorax, September 2007, BMJ

    Dr Andrew M Johnston , David Baldwin

  202. Lung cancer outcomes at a UK cancer unit between 1998–2001

    Article • Lung Cancer, August 2007, Elsevier

    David Baldwin

  203. Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway

    Article • British Journal of Cancer, September 2005, Springer Science + Business Media

    David Baldwin

  204. Evaluation of the solitary pulmonary nodule: clinical management, role of CT and nuclear medicine

    Article • Imaging, October 2004, Oxford University Press (OUP)

    David Baldwin

  205. Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy

    Article • Journal of Antimicrobial Chemotherapy, November 2002, Oxford University Press (OUP)

    David Baldwin

  206. Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2

    Article • Thorax, October 2002, BMJ

    David Baldwin

  207. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?

    Article • Thorax, September 2002, BMJ

    David Baldwin

  208. Questionnaire survey of male infertility in cystic fibrosis

    Article • Respiratory Medicine, October 2000, Elsevier

    David Baldwin

  209. Development of an expert system for the interpretation of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Midlands Thoracic Society Research Group.

    Article • Occupational and Environmental Medicine, November 1999, BMJ

    David Baldwin

  210. How Do General Practitioners Respond to Reports of Abnormal Chest X-rays?

    Article • Journal of the Royal Society of Medicine, September 1999, SAGE Publications

    David Baldwin

  211. Comparison of two new methods for the measurement of lung volumes with two standard methods

    Article • Thorax, April 1999, BMJ

    David Baldwin

  212. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

    Article • Archives of Disease in Childhood, February 1999, BMJ

    David Baldwin

  213. Comparative clinical and physiological features of Maori, Pacific Islanders and Europeans with sleep related breathing disorders

    Article • Respirology, December 1998, Wiley

    David Baldwin

  214. Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

    Article • European Journal of Orthodontics, June 1998, Oxford University Press (OUP)

    David Baldwin

  215. Pragmatics: Principals of Design and Evaluation of an Information System for a Department of Respiratory Medicine

    Article • Health Care Analysis, March 1997, Wiley

    David Baldwin

  216. Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

    Article • BMJ, January 1997, BMJ

    David Baldwin

  217. Silicosis presenting as bilateral hilar lymphadenopathy.

    Article • Thorax, November 1996, BMJ

    David Baldwin

  218. SHORT COMMUNICATION: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers

    Article • Carcinogenesis, January 1996, Oxford University Press (OUP)

    David Baldwin

  219. Effect of diuretics on allergen-induced contractions of passively sensitized human bronchi in vitro.

    Article • American Review of Respiratory Disease, October 1995, American Thoracic Society

    David Baldwin

  220. Nocturnal oxygen desaturation and exercise-induced desaturation in subjects with chronic obstructive pulmonary disease

    Article • Respiratory Medicine, October 1995, Elsevier

    David Baldwin

  221. Concentrations of ceftibuten in plasma and the respiratory tract following a single 400 mg oral dose

    Article • International Journal of Antimicrobial Agents, April 1995, Elsevier

    David Baldwin

  222. Scoring system developed for drug related morbidity

    Article • BMJ, January 1995, BMJ

    David Baldwin

  223. Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.

    Article • Thorax, November 1994, BMJ

    David Baldwin

  224. The concentration of sparfloxacin in lung tissues after single and multiple oral doses

    Article • International Journal of Antimicrobial Agents, August 1994, Elsevier

    David Baldwin

  225. The levels of clarithromycin and its 14-hydroxy metabolite in the lung

    Article • European Respiratory Journal, July 1994, European Respiratory Society (ERS)

    David Baldwin

  226. Cross refractoriness between sodium metabisulphite and exercise induced asthma.

    Article • Thorax, March 1994, BMJ

    David Baldwin

  227. Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis

    Article • Respiratory Medicine, January 1994, Elsevier

    David Baldwin

  228. The Effect of Sodium Transport and Calcium Channel Inhibitors on Phorbol Ester-induced Contraction of Bovine Airway Smooth Muscle

    Article • Pulmonary Pharmacology, December 1993, Elsevier

    David Baldwin

  229. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration

    Article • Respiratory Medicine, November 1993, Elsevier

    David Baldwin

  230. Laparoscopic cholecystectomy in patients with cystic fibrosis

    Article • Respiratory Medicine, April 1993, Elsevier

    David Baldwin

  231. Quantitative morphology and water distribution of bronchial biopsy samples.

    Article • Thorax, July 1992, BMJ

    David Baldwin

  232. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

    Article • Antimicrobial Agents and Chemotherapy, June 1992, ASM Journals

    David Baldwin

  233. Pulmonary disposition of antimicrobial agents: methodological considerations.

    Article • Antimicrobial Agents and Chemotherapy, June 1992, ASM Journals

    David Baldwin

  234. Bronchoalveolar distribution of cefaroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens

    Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

    David Baldwin

  235. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies

    Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

    David Baldwin

  236. The site concentrations of antimicrobial agents in the lung

    Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

    David Baldwin

  237. Microlavage: a technique for determining the volume of epithelial lining fluid.

    Article • Thorax, September 1991, BMJ

    David Baldwin

  238. Comparative pharmacokinetic disposition of fluoroquinolones in the lung

    Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

    David Baldwin

  239. In-vitro activity and β-lactamase stability of SR 44337, a new long acting cephalosporin

    Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

    David Baldwin

  240. In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics

    Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

    David Baldwin

  241. The penetration of cefpirome into the potential sites of pulmonary infection

    Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

    David Baldwin

  242. Concentrations of oral lomefloxacin in serum and bronchial mucosa.

    Article • Antimicrobial Agents and Chemotherapy, June 1990, ASM Journals

    David Baldwin

  243. Concentrations of temafloxacin in serum and bronchial mucosa

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 1990, Springer Science + Business Media

    David Baldwin

  244. Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

    Article • Thorax, May 1990, BMJ

    David Baldwin

  245. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose

    Article • Journal of Antimicrobial Chemotherapy, January 1990, Oxford University Press (OUP)

    David Baldwin